Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SNEX Stock Approaches 52-Week High

StoneX surged to $129.74 per share this evening, but it remains 5.48% above its mean target price of $123.0. There may still be room for more downwards movement — even after today's 4.0% drop. Analysts are giving the Large-Cap Capital Markets stock on average rating of buy, with target prices ranging from $123.0 to $123.0 per share.

StoneX has an average level of shares sold short, at 5.4% of its total share float. The stock's short ratio (also called days to cover) is 4.78. The company's insiders own 9.28% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Institutional investors own 85.8% of StoneX's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in StoneX

Date Reported Holder Percentage Shares Value
2026-03-31 Blackrock Inc. 14% 11,012,451 $1,428,755,453
2026-03-31 Vanguard Portfolio Management LLC 5% 3,740,986 $485,355,544
2026-03-31 Price (T.Rowe) Associates Inc 4% 3,471,998 $450,457,039
2026-03-31 American Century Companies Inc 4% 3,398,475 $440,918,165
2026-03-31 Vanguard Capital Management LLC 4% 3,024,896 $392,450,023
2026-03-31 State Street Corporation 4% 2,782,201 $360,962,773
2026-03-31 T. Rowe Price Investment Management, Inc. 3% 2,511,192 $325,802,063
2026-03-31 Dimensional Fund Advisors LP 3% 2,107,795 $273,465,334
2026-03-31 Geode Capital Management, LLC 3% 1,993,170 $258,593,886
2026-03-31 AltraVue Capital, LLC 2% 1,628,997 $211,346,079
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS